Related references
Note: Only part of the references are listed.Immunological Aspects of Malignant Gliomas
Or Cohen-Inbar et al.
CANADIAN JOURNAL OF NEUROLOGICAL SCIENCES (2016)
Molecular Profiling Reveals Biologically Discrete Subsets and Pathways of Progression in Diffuse Glioma
Michele Ceccarelli et al.
CELL (2016)
IDH1 mutation may not be prognostically favorable in glioblastoma when controlled for tumor location: A case-control study
Iddo Paldor et al.
JOURNAL OF CLINICAL NEUROSCIENCE (2016)
Migrating glioma cells express stem cell markers and give rise to new tumors upon xenografting
Sune Munthe et al.
JOURNAL OF NEURO-ONCOLOGY (2016)
Establishment and Characterization of a Tumor Stem Cell-Based Glioblastoma Invasion Model
Stine Skov Jensen et al.
PLOS ONE (2016)
High levels of c-Met is associated with poor prognosis in glioblastoma
Stine Asferg Petterson et al.
JOURNAL OF NEURO-ONCOLOGY (2015)
IDH1R132H mutation causes a less aggressive phenotype and radiosensitizes human malignant glioma cells independent of the oxygenation status
Jacqueline Kessler et al.
RADIOTHERAPY AND ONCOLOGY (2015)
Prognostic role of IDH mutations in gliomas: a meta-analysis of 55 observational studies
Liang Xia et al.
ONCOTARGET (2015)
LOX Expression and Functional Analysis in Astrocytomas and Impact of IDH1 Mutation
Roseli da Silva et al.
PLOS ONE (2015)
Association of matrix metalloproteinase 2 plasma level with response and survival in patients treated with bevacizumab for recurrent high-grade glioma
Emeline Tabouret et al.
NEURO-ONCOLOGY (2014)
High-Throughput Flow Cytometry Screening Reveals a Role for Junctional Adhesion Molecule A as a Cancer Stem Cell Maintenance Factor
Justin D. Lathia et al.
CELL REPORTS (2014)
Mesenchymal Differentiation Mediated by NF-κB Promotes Radiation Resistance in Glioblastoma
Krishna P. L. Bhat et al.
CANCER CELL (2013)
Tumor-Infiltrating Lymphocytes in Glioblastoma Are Associated with Specific Genomic Alterations and Related to Transcriptional Class
W. Caleb Rutledge et al.
CLINICAL CANCER RESEARCH (2013)
MiR-21 expression in the tumor cell compartment holds unfavorable prognostic value in gliomas
Simon Kjaer Hermansen et al.
JOURNAL OF NEURO-ONCOLOGY (2013)
A population-based study of low-grade gliomas and mutated isocitrate dehydrogenase 1 (IDH1)
Rikke H. Dahlrot et al.
JOURNAL OF NEURO-ONCOLOGY (2013)
Prognostic value of Musashi-1 in gliomas
Rikke H. Dahlrot et al.
JOURNAL OF NEURO-ONCOLOGY (2013)
Glioma Spheroids Obtained via Ultrasonic Aspiration Are Viable and Express Stem Cell Markers: A New Tissue Resource for Glioma Research
Stine Skov Jensen et al.
NEUROSURGERY (2013)
Transcriptional Factors for Epithelial-Mesenchymal Transition Are Associated with Mesenchymal Differentiation in Gliosarcoma
Masaya Nagaishi et al.
BRAIN PATHOLOGY (2012)
Primary human glioblastomas - prognostic value of clinical and histopathological parameters
Andreas H. Habberstad et al.
CLINICAL NEUROPATHOLOGY (2012)
Predictive impact of MGMT promoter methylation in glioblastoma of the elderly
Guido Reifenberger et al.
INTERNATIONAL JOURNAL OF CANCER (2012)
Temozolomide versus standard 6-week radiotherapy versus hypofractionated radiotherapy in patients older than 60 years with glioblastoma: the Nordic randomised, phase 3 trial
Annika Malmstrom et al.
LANCET ONCOLOGY (2012)
Temozolomide chemotherapy alone versus radiotherapy alone for malignant astrocytoma in the elderly: the NOA-08 randomised, phase 3 trial
Wolfgang Wick et al.
LANCET ONCOLOGY (2012)
Glioblastoma resistance to anti-VEGF therapy is associated with myeloid cell infiltration, stem cell accumulation, and a mesenchymal phenotype
Yuji Piao et al.
NEURO-ONCOLOGY (2012)
Current Concepts and Management of Glioblastoma
Matthias Preusser et al.
ANNALS OF NEUROLOGY (2011)
Membrane connectivity estimated by digital image analysis of HER2 immunohistochemistry is concordant with visual scoring and fluorescence in situ hybridization results: algorithm evaluation on breast cancer tissue microarrays
Aida Laurinaviciene et al.
DIAGNOSTIC PATHOLOGY (2011)
Effects of hypoxia on expression of a panel of stem cell and chemoresistance markers in glioblastoma-derived spheroids
Jesper Kolenda et al.
JOURNAL OF NEURO-ONCOLOGY (2011)
Serum angiogenic profile of patients with glioblastoma identifies distinct tumor subtypes and shows that TIMP-1 is a prognostic factor
Matthew Crocker et al.
NEURO-ONCOLOGY (2011)
The prognostic IDH1 R132 mutation is associated with reduced NADP+-dependent IDH activity in glioblastoma
Fonnet E. Bleeker et al.
ACTA NEUROPATHOLOGICA (2010)
Integrated Genomic Analysis Identifies Clinically Relevant Subtypes of Glioblastoma Characterized by Abnormalities in PDGFRA, IDH1, EGFR, and NF1
Roel G. W. Verhaak et al.
CANCER CELL (2010)
Phase II Study of Cediranib, an Oral Pan-Vascular Endothelial Growth Factor Receptor Tyrosine Kinase Inhibitor, in Patients With Recurrent Glioblastoma
Tracy T. Batchelor et al.
JOURNAL OF CLINICAL ONCOLOGY (2010)
Clinical implications and prognostic value of EMMPRIN/CD147 and MMP2 expression in pediatric gliomas
Jian Gu et al.
EUROPEAN JOURNAL OF PEDIATRICS (2009)
Low expression of tissue inhibitor of metalloproteinases-1 (TIMP-1) in glioblastoma predicts longer patient survival
Charlotte Aaberg-Jessen et al.
JOURNAL OF NEURO-ONCOLOGY (2009)
Evaluation of the value of frozen tissue section used as gold standard for immunohistochemistry
Shan-Rong Shi et al.
AMERICAN JOURNAL OF CLINICAL PATHOLOGY (2008)
CD133 identifies perivascular niches in grade II-IV astrocytomas
Karina Christensen et al.
JOURNAL OF NEURO-ONCOLOGY (2008)
Comprehensive genomic characterization defines human glioblastoma genes and core pathways
L. Chin et al.
NATURE (2008)
Malignant gliomas in adults
Patrick Y. Wen et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
Molecular subclasses of high-grade glioma predict prognosis, delineate a pattern of disease progression, and resemble stages in neurogenesis
HS Phillips et al.
CANCER CELL (2006)
Scatter factor/hepatocyte growth factor in brain tumor growth and angiogenesis
R Abounader et al.
NEURO-ONCOLOGY (2005)
Metalloproteinases and their inhibitors in tumor angiogenesis
MM Handsley et al.
INTERNATIONAL JOURNAL OF CANCER (2005)
Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma
R Stupp et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
Hypoxia promotes invasive growth by transcriptional activation of the met protooncogene
S Pennacchietti et al.
CANCER CELL (2003)
Metalloproteinase inhibitors: biological actions and therapeutic opportunities
AH Baker et al.
JOURNAL OF CELL SCIENCE (2002)
New functions for the matrix metalloproteinases in cancer progression
M Egeblad et al.
NATURE REVIEWS CANCER (2002)
Metalloproteinases in biology and pathology of the nervous system
VW Yong et al.
NATURE REVIEWS NEUROSCIENCE (2001)
Matrix metalloproteinase 2 (MMP-2) immunoreactive protein is associated with poor grade and survival in brain neoplasms
J Jaalinoja et al.
JOURNAL OF NEURO-ONCOLOGY (2000)
Share Paper
